[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100651504":3},{"organization":4,"armGroups":7,"interventions":14,"overallOfficials":20,"centralContacts":28,"locations":33,"responsibleParty":52,"collaborators":19,"id":56,"slug":57,"hasResults":58,"nctId":59,"briefTitle":60,"officialTitle":60,"acronym":61,"eligibilityCriteria":62,"healthyVolunteers":58,"sex":63,"minAge":64,"maxAge":19,"enrollmentInfo":65,"targetDuration":19,"studyType":68,"phases":69,"briefSummary":71,"conditions":72,"keywords":74,"overallStatus":83,"whyStopped":19,"lastUpdateSubmitDate":84,"lastUpdatePostDateStruct":85,"startDateStruct":88,"completionDateStruct":90,"leadSponsor":92,"locationsCount":93},{"fullName":5,"class":6},"University of Texas at Austin","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"WILD 5 Wellness Program","EXPERIMENTAL","Participants will complete the 30-day WILD 5 Wellness program, which includes daily practices related to exercise, mindfulness, sleep, social connection, and nutrition.",[13],"Behavioral: WILD 5 Wellness Program",[15],{"type":16,"name":9,"description":17,"armGroupLabels":18,"otherNames":19},"BEHAVIORAL","A 30-day structured wellness program that includes daily practices in five areas: exercise, mindfulness, sleep, social connection, and nutrition. Participants complete the wellness practices independently and complete daily online tracking during the 30-day program.",[9],null,[21,25],{"name":22,"affiliation":23,"role":24},"Saundra Jain, MA, PsyD, LPC","The University of Texas at Austin School of Nursing","PRINCIPAL_INVESTIGATOR",{"name":26,"affiliation":27,"role":24},"Rakesh Jain, MD, MPH","Texas Tech University Health Sciences Center School of Medicine - Permian Basin",[29],{"name":22,"role":30,"phone":31,"phoneExt":19,"email":32},"CONTACT","888-252-7806","saundrajain@gmail.com",[34],{"facility":35,"status":19,"city":36,"state":37,"zip":38,"country":39,"countryCode":40,"cosmosGeoPoint":41,"geoPoint":46,"contacts":47},"The GLOW Study","The Colony","Texas","75056","United States","US",{"type":42,"coordinates":43},"Point",[44,45],-96.88639,33.08901,{"lat":45,"lon":44},[48,49,50,51],{"name":22,"role":30,"phone":31,"phoneExt":19,"email":32},{"name":19,"role":30,"phone":19,"phoneExt":19,"email":32},{"name":22,"role":24,"phone":19,"phoneExt":19,"email":19},{"name":26,"role":24,"phone":19,"phoneExt":19,"email":19},{"type":53,"investigatorFullName":54,"investigatorTitle":55,"investigatorAffiliation":5,"oldNameTitle":19,"oldOrganization":19},"SPONSOR_INVESTIGATOR","Saundra Jain","Adjunct Clinical Affiliate","100651504","the-glow-study-glp-1-and-lifestyle-for-optimal-wellness-100651504",false,"NCT07760896","The GLOW Study: GLP-1 and Lifestyle for Optimal Wellness","GLOW","Inclusion Criteria: Age 18 years or older. Able to speak, read, and understand English. Interested in supporting physical and emotional well-being. Access to a reliable Internet-enabled device, such as a computer, smartphone, or tablet.\n\nPossess basic skills needed to complete online study forms. Currently prescribed and taking a GLP-1 receptor agonist or dual GIP\u002FGLP-1 receptor agonist by a licensed healthcare practitioner.\n\nReport that the medication was prescribed for an FDA-approved indication, such as type 2 diabetes mellitus, chronic weight management for obesity or overweight with at least one weight-related condition, moderate-to-severe obstructive sleep apnea in adults with obesity, or another FDA-approved cardiometabolic indication.\n\nWilling to complete online consent, registration, program measures, and daily tracking forms.\n\nWilling to participate in the 30-day WILD 5 Wellness program delivered as part of the GLOW Study.\n\n\\-\n\nExclusion Criteria: Under 18 years of age. Unable to speak, read, or understand English. Do not have access to a reliable Internet-enabled device. Do not possess basic skills needed to complete online study forms. Not currently prescribed and taking a GLP-1 receptor agonist or dual GIP\u002FGLP-1 receptor agonist by a licensed healthcare practitioner.\n\nReport that the medication was not prescribed for an FDA-approved indication. Pregnant or planning to become pregnant in the next 30 days. Currently have thoughts about harming themselves or someone else. Currently experiencing symptoms suggestive of active psychosis. Unwilling or unable to complete the required online study forms or participate in the 30-day\n\n\\-","ALL","18 Years",{"count":66,"type":67},200,"ESTIMATED","INTERVENTIONAL",[70],"NA","The goal of this clinical trial is to learn whether a 30-day structured wellness program may support physical and emotional well-being in adults who are already taking a GLP-1 or dual GIP\u002FGLP-1 medication for an FDA-approved indication. The study does not evaluate the GLP-1 medication itself or make changes to participants' medication treatment.\n\nThe main questions it aims to answer are:\n\n1. Are there changes in participants' physical and emotional well-being after completing the 30-day wellness program?\n2. Are there changes in areas such as mood, anxiety, functioning, mindfulness, self-compassion, eating-related behaviors, pain, and positive wellness?\n\nParticipants will:\n\n1. Complete online questionnaires before and after the program.\n2. Follow the WILD 5 Wellness program for 30 days, which includes daily practices related to exercise, mindfulness, sleep, social connection, and nutrition.\n3. Complete a brief online tracking form each day during the 30-day program.",[73],"Wellness",[75,76,77,78,79,80,81,82],"GLP-1","GLP-1 Receptor Agonist","GIP\u002FGLP-1 Receptor Agonist","Lifestyle Intervention","WILD 5 Wellness","Physical Well-Being","Emotional Well-Being","Self-Management","NOT_YET_RECRUITING","2026-08-07",{"date":86,"type":87},"2026-08-12","ACTUAL",{"date":89,"type":67},"2026-09-01",{"date":91,"type":67},"2027-10",{"name":54,"class":6},1]